Yu Hyeon Choi

Yu Hyeon Choi

Auto-generated profile, based on publicly available information

Yu Hyeon Choi

Department of Pediatrics, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
YCYu Hyeon Choi
Yu Hyeon Choi
ILIn Hwa Lee
In Hwa Lee
MYMihee Yang
Mihee Yang
YCYoon Sook Cho
Yoon Sook Cho
YJYun Hee Jo
Yun Hee Jo
JPJune Dong Park
June Dong Park
Despite the high prevalence of potential drug–drug interactions in pediatric intensive care units, their clinical relevance and significance are unclear. We assessed the characteristics and risk factors of clinically relevant potential drug–drug interactions to facilitate their efficient monitoring in pediatric intensive care units. This retrospective cohort study reviewed the medical records of 159 patients aged <19 years who were hospitalized in the pediatric intensive care unit at Seoul National University Hospital (Seoul, Korea) for ≥3 days between August 2019 and February 2020. Potential drug–drug interactions were screened using the Micromedex Drug-Reax® system. Clinical relevance of each potential drug–drug interaction was reported with official terminology, magnitude of severity, and causality, and the association with the patient’s clinical characteristics was assessed. In total, 115 patients (72.3%) were exposed to 592 potential interactions of 258 drug pairs. In 16 patients (10.1%), 22 clinically relevant potential drug–drug interactions were identified for 19 drug pairs. Approximately 70% of the clinically relevant potential drug–drug interactions had a severity grade of ≥3. Exposure to potential drug–drug interactions was significantly associated with an increase in the number of administrated medications (6–7 medications, p = 0.006; ≥8, p<0.001) and prolonged hospital stays (1–2 weeks, p = 0.035; ≥2, p = 0.049). Moreover, clinically relevant potential drug–drug interactions were significantly associated with ≥8 prescribed drugs (p = 0.019), hospitalization for ≥2 weeks (p = 0.048), and ≥4 complex chronic conditions (p = 0.015). Most potential drug–drug interactions do not cause clinically relevant adverse outcomes in pediatric intensive care units. However, because the reactions that patients experience from clinically relevant potential drug–drug interactions are often very severe, there is a medical need to implement an appropriate monitoring system for potential drug–drug interactions according to the pediatric intensive care unit characteristics.

1 January 2018 in Journal of Korean Medical Science
Verified
Journal Article
Open access
JYJong-Seo Yoon
Jong-Seo Yoon
WJWon Kyoung Jhang
Won Kyoung Jhang
YCYu Hyeon Choi
Yu Hyeon Choi
Bongjin LeeBongjin Lee
Bongjin Lee
YKYoung Hyun Kim
Young Hyun Kim
KMKorean Society of Pediatric Critical Care Medicine
Korean Society of Pediatric Critical Care Medicine
Yoon JS, et al. J Korean Med Sci. 2018 Dec;33(49):e308. https://doi.org/10.3346/jkms.2018.33.e308

26 October 2022 in Acute and Critical Care
Verified
Journal Article
Open access
PDF file
YSYunseob Shin
Yunseob Shin
KCKyungjae Cho
Kyungjae Cho
YLYeha Lee
Yeha Lee
YCYu Hyeon Choi
Yu Hyeon Choi
JJJae Hwa Jung
Jae Hwa Jung
WJWon Kyoung Jhang
Won Kyoung Jhang
Background: Early recognition of deterioration events is crucial to improve clinical outcomes. For this purpose, we developed a deep-learning-based pediatric early-warning system (pDEWS) and aimed to validate its clinical performance. Methods: This is a retrospective multicenter cohort study including five tertiary-care academic children’s hospitals. All pediatric patients younger than 19 years admitted to the general ward from January 2019 to December 2019 were included. Using patient electronic medical records, we evaluated the clinical performance of the pDEWS for identifying deterioration events defined as in-hospital cardiac arrest (IHCA) and unexpected general ward-to-pediatric intensive care unit transfer (UIT) within 24 hours before event occurrence. We also compared pDEWS performance to those of the modified pediatric early-warning score (PEWS) and prediction models using logistic regression (LR) and random forest (RF). Results: The study population consisted of 28,758 patients with 34 cases of IHCA and 291 cases of UIT. pDEWS showed better performance for predicting deterioration events with a larger area under the receiver operating characteristic curve, fewer false alarms, a lower mean alarm count per day, and a smaller number of cases needed to examine than the modified PEWS, LR, or RF models regardless of site, event occurrence time, age group, or sex. Conclusions: The pDEWS outperformed modified PEWS, LR, and RF models for early and accurate prediction of deterioration events regardless of clinical situation. This study demonstrated the potential of pDEWS as an efficient screening tool for efferent operation of rapid response teams.

10 August 2020 in Pediatric Transplantation
Verified
Journal Article
Closed access
PDF file
SSSohyun Shin
Sohyun Shin
DSDong In Suh
Dong In Suh
JKJung Min Ko
Jung Min Ko
JPJune Dong Park
June Dong Park
JLJeong-Moo Lee
Jeong-Moo Lee
YCYu Hyeon Choi
Yu Hyeon Choi

1 January 2019 in Journal of Korean Medical Science
Verified
Journal Article
Open access
Bongjin LeeBongjin Lee
Bongjin Lee
JPJune Dong Park
June Dong Park
YCYu Hyeon Choi
Yu Hyeon Choi
YHYoung Joo Han
Young Joo Han
DSDong In Suh
Dong In Suh
Lee B, et al. J Korean Med Sci. 2019 Jan;34(3):e21. https://doi.org/10.3346/jkms.2019.34.e21

1 January 2024 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
YCYu Hyeon Choi
Yu Hyeon Choi
WJWon Kyoung Jhang
Won Kyoung Jhang
SPSeong Jong Park
Seong Jong Park
HCHee Joung Choi
Hee Joung Choi
MOMin-Su Oh
Min-Su Oh
YKYounga Kim
Younga Kim
Choi YH, et al. J Korean Med Sci. 2024 Jan;39(3):e33. https://doi.org/10.3346/jkms.2024.39.e33